telehealth services compounded tirzepatide injections Compounded Tirzepatide Program: Results, Timeline

For example, Bose et al

The study began enrollment in January 2024 and is investigator-initiated at Hvidovre Hospital in Denmark with recruitment completed and preliminary data published in January 2025, showing modest efficacy signals with 3 of 9 patients (33%) achieving remission overall though tolerability concerns led to early discontinuation in several participants

Gerstein HC, Li Z, Ramasundarahettige C, Baek S, Branch KRH, Del Prato S, et al

Weight loss with glucagon-like peptide-1 receptor agonists in Bardet-Biedl syndrome

With ongoing provider oversight and support, patients can move forward with clarity and confidence, knowing their care is designed to work with their body, not against it

Genes (Basel), 2023, 14(2)